RIPK1 and Parkinson disease: This concept is analogous, but distinct, from RIPK1 modulating RIPK3 activity to promote TNFα-mediated necroptosis (Zhang D. W. et al., 2009), and is of interest as RIPK1 is also a potential therapeutic target for inflammatory diseases including PD (Yuan et al., 2019).